Your browser doesn't support javascript.
loading
Robustness of a continuous direct compression line against disturbances in feeding.
Karttunen, A-P; Poms, J; Sacher, S; Sparén, A; Ruiz Samblás, C; Fransson, M; Martin De Juan, L; Remmelgas, J; Wikström, H; Hsiao, W-K; Folestad, S; Korhonen, O; Abrahmsén-Alami, S; Tajarobi, P.
Afiliação
  • Karttunen AP; School of Pharmacy, University of Eastern Finland, Kuopio, Finland. Electronic address: anssi-pekka.karttunen@uef.fi.
  • Poms J; Research Center Pharmaceutical Engineering GmbH, Graz, Austria.
  • Sacher S; Research Center Pharmaceutical Engineering GmbH, Graz, Austria.
  • Sparén A; Pharmaceutical Technology & Development, AstraZeneca, Gothenburg, Sweden.
  • Ruiz Samblás C; Pharmaceutical Technology & Development, AstraZeneca, Gothenburg, Sweden.
  • Fransson M; Pharmaceutical Technology & Development, AstraZeneca, Gothenburg, Sweden.
  • Martin De Juan L; Pharmaceutical Technology & Development, AstraZeneca, Gothenburg, Sweden.
  • Remmelgas J; Pharmaceutical Technology & Development, AstraZeneca, Gothenburg, Sweden.
  • Wikström H; Pharmaceutical Technology & Development, AstraZeneca, Gothenburg, Sweden.
  • Hsiao WK; Research Center Pharmaceutical Engineering GmbH, Graz, Austria.
  • Folestad S; Pharmaceutical Technology & Development, AstraZeneca, Gothenburg, Sweden.
  • Korhonen O; School of Pharmacy, University of Eastern Finland, Kuopio, Finland.
  • Abrahmsén-Alami S; Pharmaceutical Technology & Development, AstraZeneca, Gothenburg, Sweden.
  • Tajarobi P; Pharmaceutical Sciences, AstraZeneca, Gothenburg, Sweden.
Int J Pharm ; 574: 118882, 2020 Jan 25.
Article em En | MEDLINE | ID: mdl-31786355
The aim of the current study was to characterize the robustness of an integrated continuous direct compression (CDC) line against disturbances from feeding, i.e. impulses of API and short step disturbances. These disturbances mimicked typical variations that can be encountered during long-term manufacture. The study included a primary formulation, with API of standard particle size, which was manufactured at 5 and 10 kg/h production rates, and a modified formulation, with API of large particle size, which was manufactured at 5 kg/h production rate. Overall, the CDC line smoothened all the disturbances, fulfilling the USP uniformity of dosage units (UDU) limit for single tablets. However, runs with the modified formulation failed the pharmacopoeia UDU requirements for the entire run due to high variation between tablets. The primary formulation passed the requirements in all cases. The residence time distribution (RTD) results indicated that the primary formulation allowed better smoothening ability, and an increase in production rate led to poorer smoothening due to shorter RTD. The RTDs revealed that a substantial part of back-mixing took place after the blender. Thus, the tablet press has an important role in smoothening disturbances longer than the mean residence time of the blender, which was very short.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Comprimidos Idioma: En Revista: Int J Pharm Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Comprimidos Idioma: En Revista: Int J Pharm Ano de publicação: 2020 Tipo de documento: Article